Ideggyógyászati Szemle,
Год журнала:
2024,
Номер
77(5-6), С. 151 - 159
Опубликована: Янв. 1, 2024
Background
–
Long
Covid
is
a
complex
condition
characterised
by
symptoms
that
persist
for
weeks
and
months
after
the
infection,
accompanied
cognitive
impairment
negatively
affects
daily
life.
Understanding
this
important
development
of
diagnostic
therapeutic
strategies.
Purpose
This
article
aims
to
provide
comprehensive
overview
impairment
in
long-COVID,
including
its
definition,
symptoms,
pathophysiology,
risk
factors,
assessment
tools,
imaging
abnormalities,
potential
biomarkers,
management
strategies,
long-term
outcomes,
future
directions
research.
Methods
The
search
methodology
used
review
aimed
include
wide
range
research
on
related
both
COVID-19
long-COVID.
Systematic
searches
PubMed
Google
Scholar
databases
were
conducted
using
mixture
MeSH
terms
keywords
‘cognition’,
‘cognitive
impairment’,
‘brain
fog’,
‘COVID-19’
‘long-COVID’.
was
restricted
studies
published
English
between
1
January
2019
11
February
2024,
which
presented
findings
neurological
manifestations
human
participants.
Results
Long-COVID
characterized
persistent
following
with
being
prominent
feature.
Symptoms
brain
fog,
difficulties
concentration,
memory
issues,
executive
function
deficits.
Pathophysiological
mechanisms
involve
viral
persistence,
immune
responses,
vascular
damage.
Risk
factors
age,
pre-existing
conditions,
disease
severity.
Cognitive
tools
such
as
Montreal
Assessment
(MoCA)
are
essential
diagnosis.
Imaging
studies,
MRI,
PET,
SPECT,
reveal
structural
functional
alterations.
Potential
biomarkers
C-reactive
protein,
interleukin-6,
neuron-specific
enolase.
Management
strategies
encompass
rehabilitation,
occupational
therapy,
medications,
lifestyle
modifications.
Discussion
poses
multifaceted
challenge,
significantly
impacts
patients’
lives.
A
multidisciplinary
approach,
rehabilitation
medication
when
appropriate,
effective
management.
Future
should
focus
validating
understanding
outcomes.
Conclusion
global
health
concern,
distressing
symptom.
While
pharmacological
interventions
have
potential,
they
require
careful
consideration.
Continued
crucial
improving
treatment
Life,
Год журнала:
2024,
Номер
14(2), С. 279 - 279
Опубликована: Фев. 19, 2024
Neurological
disorders
have
been
reported
in
a
large
number
of
coronavirus
disease
2019
(COVID-19)
patients,
suggesting
that
this
may
long-term
adverse
neurological
consequences.
COVID-19
occurs
from
infection
by
positive-sense
single-stranded
RNA
virus
called
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
The
membrane
fusion
protein
SARS-CoV-2,
the
spike
protein,
binds
to
its
human
host
receptor,
angiotensin-converting
enzyme
(ACE2),
initiate
between
and
cell.
SARS-CoV-2
contains
furin
protease
recognition
site
cleavage
enhances
infectivity
virus.
binding
ACE2
receptor
has
shown
downregulate
ACE2,
thereby
increasing
levels
pathogenic
angiotensin
II
(Ang
II).
cleaves
S1
subunit
with
domain
toward
S2
transmembrane
anchors
viral
membrane,
activity
releases
into
blood
circulation.
released
also
downregulates
turn
level
Ang
II.
Considering
particle
many
molecules,
furin-dependent
would
release
free
each
which
can
while
only
affects
one
molecule.
Therefore,
dramatically
amplify
ability
produce
We
hypothesize
amplification
mechanism
possesses,
but
not
per
se,
is
major
driving
force
behind
COVID-19-associated
disorders.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2024,
Номер
14
Опубликована: Апрель 4, 2024
SARS-CoV-2-induced
excessive
inflammation
in
brain
leads
to
damage
of
blood-brain
barrier,
hypoxic-ischemic
injury,
and
neuron
degeneration.
The
production
inflammatory
cytokines
by
microvascular
endothelial
cells
microglia
is
reported
be
critically
associated
with
the
pathology
COVID-19
patients.
However,
cellular
mechanisms
for
SARS-CoV-2-inducing
activation
subsequent
neuroinflammation
remain
fully
delineated.
Our
research,
along
others',
has
recently
demonstrated
that
accumulation
mast
(MCs)
mouse
lung
could
further
induce
consequent
damages.
Intracerebral
MCs
their
cross
talk
other
play
important
roles
neurodegenerative
diseases
including
virus-induced
neuro-pathophysiology.
In
this
study,
we
investigated
role
MC
neuroinflammation.
We
found
(1)
SARS-CoV-2
infection
triggered
cerebrovascular
region
mice;
(2)
spike/RBD
(receptor-binding
domain)
protein-triggered
induced
factors
human
microglia;
(3)
degranulation
destroyed
tight
junction
proteins
proliferation
microglia.
These
findings
reveal
a
mechanism
Frontiers in Microbiology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 15, 2024
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
the
etiological
agent
of
COVID-19,
is
known
to
infect
people
all
ages
and
both
sexes.
Senior
populations
have
greatest
risk
severe
sexual
dimorphism
in
clinical
outcomes
has
been
reported.
Neurological
symptoms
are
widely
observed
COVID-19
patients,
with
many
survivors
exhibiting
persistent
neurological
cognitive
impairment.
The
present
study
aims
investigate
impact
age
sex
on
neuroinflammatory
response
SARS-CoV-2
infection
using
a
mouse
model.
Wild-type
C57BL/6J
mice
were
intranasally
inoculated
lineage
B.1.351,
variant
mice.
Older
male
exhibited
significantly
greater
weight
loss
higher
viral
loads
lung
at
3
days
post
infection.
Notably,
no
RNA
was
detected
brains
infected
Nevertheless,
expression
IL-6,
TNF-α,
CCL-2
brain
increased
RNA-seq
transcriptomic
analysis
showed
that
caused
significant
changes
gene
profiles,
implicating
innate
immunity,
defense
virus,
cerebrovascular
neuronal
functions.
These
findings
demonstrate
triggers
response,
despite
lack
detectable
virus
brain.
Aberrant
activation
immune
disruption
blood-brain
barrier
endothelial
cell
integrity,
suppression
activity
axonogenesis
underlie
Understanding
role
these
affected
pathways
pathogenesis
helps
identify
appropriate
points
therapeutic
interventions
alleviate
dysfunction
during
COVID-19.
Cytokines and inflammation,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 4, 2025
In
2023,
the
pandemic
of
new
coronavirus
infection
caused
by
SARS-CoV-2
was
declared
over
WHO.
Apparently,
has
become
a
seasonal
respiratory
viral
infection.
Among
problems
remaining
after
end
pandemic,
one
leading
places
is
occupied
post-Covid
syndrome
-
condition
associated
with
persistence
symptoms
COVID-19
or
reappearance
3
months
illness.
Most
common
features
are:
immune
dysregulation,
persistence,
continued
systemic
inflammation,
autoimmune
dysorders,
tromboses
and
endothelial
damage,
myocarditis,
ischemic
cardial
disease,
lung
fibrosis.
These
different
organ
dysfunctions
are
accompanied
neurological
complications.
Precise
pathophysiological
mechanisms
to
be
discovered.
The
review
addresses
issues
pathogenesis
syndrome.
Frontiers in Microbiology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 29, 2025
Background
Currently,
vaccination
has
consistently
posed
challenges
in
preventing
the
Porcine
reproductive
and
respiratory
syndrome
virus
(PRRSV),
so
there
is
an
urgent
need
for
effective
controlling
strategies.
Ma-Xing-Shi-Gan-San
(MXSGS),
a
traditional
Chinese
medicine
(TCM)
formula
used
pulmonary
diseases
disorders,
proven
treating
H1N1
COVID-19.
Herein,
we
evaluated
whether
MXSGS
exhibits
potent
antiviral
activity
against
PRRSV.
Methods
First,
PRRSV-infected
Marc-145
cell
model
was
established.
Reverse
transcription-quantitative
polymerase
chain
reaction
(RT-qPCR)
tissue
culture
infective
dose
(TCID₅₀)
assay
were
performed
to
assess
inhibitory
effects
of
on
PRRSV
during
different
administration
stages.
Network
pharmacology
then
employed
identify
key
active
ingredients
core
potential
targets
In
addition,
gene
ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
analyses
conducted
elucidate
signaling
pathways
modulated
by
MXSGS.
Lastly,
candidate
validated
molecular
docking
analysis.
Results
significantly
inhibited
through
prophylactic
therapeutic
suppressed
multiple
phases
viral
life
cycle,
including
attachment,
internalization,
replication,
release.
network
results,
82
118
related
identified.
Among
them,
Calycosin,
Odoratin,
Glyzaglabrin,
7,2′,4′-trihydroxy-5-methoxy-3-arylcoumarin,
Eriodictyol
selected
as
ingredients.
ALB,
PPARG,
CASP3,
STAT3,
TGFB1,
JAK2,
TLR4,
PRKACA,
PRKACB
screened
targets.
Furthermore,
pathway
functional
enrichment
analysis
revealed
that
impact
mainly
involved
Toll-like
receptor
pathway,
typical
NF-κB
signaling,
positive
regulation
interleukin-6
production,
Th17
differentiation,
inflammatory
response,
defense
response.
indicated
excellent
binding
affinity
between
ingredients,
with
all
energies
<
−6.0
kcal/mol.
Conclusion
vitro
experiments
exhibited
considerable
anti-PRRSV
activity.
Using
approaches,
five
six
identified,
underscoring
promising
pharmaceutical
agent
International Archives of Allergy and Immunology,
Год журнала:
2024,
Номер
185(8), С. 803 - 809
Опубликована: Янв. 1, 2024
<b><i>Introduction:</i></b>
Mast
cells
are
known
for
their
involvement
in
allergic
reactions
but
also
inflammatory
via
secretion
of
numerous
pro-inflammatory
chemokines,
cytokines,
and
enzymes.
Drug
development
has
focused
on
antiproliferative
therapy
systemic
mastocytosis
not
inhibitors
mast
cell
activation.
The
only
drug
available
as
a
“mast
blocker”
is
disodium
cromoglycate
(cromolyn),
it
poorly
absorbed
after
oral
administration,
weak
inhibitor
histamine
release
from
human
cells,
develops
rapid
anaphylaxis.
Instead,
certain
natural
flavonoids,
especially
luteolin,
can
inhibit
<b><i>Methods:</i></b>
Here,
we
compared
pretreatment
(0–120
min)
with
equimolar
concentration
(effective
dose
50%
inhibition
=
100
m<sc>m</sc>
by
cromolyn)
cromolyn
luteolin
mediators
the
cultured
LADR
line
stimulated
either
immunoglobulin
E
(IgE)
anti-IgE
or
IL-33.
<b><i>Results:</i></b>
We
show
that
significantly
more
potent
than
inhibiting
histamine,
tryptase,
metalloproteinase-9,
vascular
endothelial
growth
factor.
Moreover,
while
inhibited
IL-1β,
IL-6,
IL-8
(CXCL8)
TNF,
had
no
effect.
<b><i>Conclusion:</i></b>
These
findings
support
use
liposomal
form
to
increase
absorption,
may
be
useful
alternative
cromolyn.
Allergy medicine.,
Год журнала:
2024,
Номер
1, С. 100003 - 100003
Опубликована: Сен. 1, 2024
Mast
cells
(MC)
are
found
perivascularly
in
all
tissues
and
may
function
as
the
sentinel
immune
sensing
danger
then
acting
master
conductor
to
orchestrate
responses
aimed
at
restoring
homeostasis.
Yet,
MC
best
known
for
their
critical
role
allergic,
but
also
inflammatory
other
neuroimmune
conditions.
stimulated
by
allergens,
many
environmental,
neuroimmune,
pathogenic
stress
triggers.
Stimulation
of
is
called
"activation"
associated
with
release
numerous
neurohormonal,
proinflammatory,
tissue
remodeling
vasoactive
mediators
via
different
secretory
mechanisms,
some
which
do
not
involve
histamine
tryptase.
However,
mast
cell
activation
subsequent
become
excessive
either
because
persistent
stimulation
or
dysregulation.
Clinical
experimental
evidence
indicates
that
be
regulated
innate
molecules,
derived
from
MC,
themselves.
discovery
such
innate,
natural,
inhibitors
has
been
a
priority
even
though
they
would
substantially
change
treatment
disorders
(MCADs)
since
drugs
available
under
development
focus
on
inducing
apoptosis.
Development
effective
require
access
healthy
MCAD
subjects,
preferably
identical
twins,
allow
differential
investigation
respective
transcriptome.